References
Advani, A. S., Atkeson, B., Brown, C. L., Peterson, B. L., Fish, L., Johnson, J. L., … Gautier, M. (2003). Barriers to the participation of African-American patients with cancer in clinical trials. Cancer, 97, 1499-1506. dx.doi.org/10.1002/cncr.11213
Agrawal, M., Grady, C., Fairclough, D. L., Meropol, N. J., Maynard, K., & Emanuel, E. (2006). Patients' decision-making process regarding participation in phase I oncology research. Journal of Clinical Oncology, 24, 4479-4484. dx.doi.org/10.1200/JCO.2006.06.0269
Albrecht, T. L., Eggly, S. S., Gleason, M. E., Harper, F. W., Foster, T. S., Peterson, A. M., … Ruckdeschel, J. C. (2008). Influence of clinical communication on patients' decision making on participation in clinical trials. Journal of Clinical Oncology, 26, 2666-2673. dx.doi.org/10.1200/JCO.2007.14.8114
American Cancer Society. (2009). Cancer facts and figures, 2009. Atlanta, GA: Author.
Avis, N. E., Smith, K. W., Link, C. L., Hortobagyi, G. N., & Rivera, E. (2006). Factors associated with participation in breast cancer treatment clinical trials. Journal of Clinical Oncology, 24, 1860-1867. dx.doi.org/10.1200/JCO.2005.03.8976
Bennett, C. L., Adams, J. R., Knox, K. S., Kelahan, A. M., Silver, S. M., & Bailes, J. S. (2001). Clinical trials: Are they a good buy?
Journal of Clinical Oncology, 19, 4330-4339. Retrieved from
http://jco.ascopubs.org/content/19/23/4330.long http://jco.ascopubs.org/content/19/23/4330.long
Buss, M. K., DuBenske, L. L., Dinauer, S., Gustafson, D. H., McTavish, F., & Cleary, J. F. (2008). Patient/caregiver influences for declining participation in supportive oncology trials. Journal of Supportive Oncology, 6, 168-174.
Cheng, J. D., Hitt, J., Koczwara, B., Schulman, K. A., Burnett, C. B., Gaskin, D. J., … Meropol, N. J. (2000). Impact of quality of life on patient expectations regarding phase I clinical trials. Journal of Clinical Oncology, 18, 421-428.
Cohen, M. Z., Slomka, J., Pentz, R. D., Flamm, A. L., Gold, D., Herbst, R. S., & Abbruzzese, J. L. (2007). Phase I participants' views of quality of life and trial participation burdens. Supportive Care in Cancer, 15, 885-890. dx.doi.org/10.1007/s00520-007-0216-0
Daugherty, C. K., Fitchett, G., Murphy, P. E., Peterman, A. H., Banik, D. M., Hlubocky, F., & Tartaro, J. (2005). Trusting God and medicine: Spirituality in advanced cancer patients volunteering for clinical trials of experimental agents. Psycho-Oncology, 14, 135-146. dx.doi.org/10.1002/pon.829
DeAngelis, C. D., Drazen, J. M., Frizelle, F. A., Haug, C., Hoey, J., Horton, R., … Van Der Weyden, M. B. (2005). Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors [Editorial]. JAMA, 293, 2927-2929. dx.doi.org/10:1001/jama.293.23.jed50037
de Cenival, M. (2008). [Ethics of research: The freedom to withdraw.] Bulletin de la Societe de Pathologie Exotique, 101, 98-101.
Epstein, R. M., & Street, R. L., Jr. (2007). Patient-centered communication in cancer care: Promoting healing and reducing suffering [Publication 07-6225]. Bethesda, MD: National Cancer Institute.
Ford, J. G., Howerton, M. W., Lai, G. Y., Gary, T. L., Bolen, S., Gibbons, M. C., … Bass, E. B. (2008). Barriers to recruiting underrepresented populations to cancer clinical trials: A systematic review. Cancer, 112, 228-242. dx.doi.org/10.1002/cncr.23157
Gaskin, D. J., Weinfurt, K. P., Castel, L. D., DePuy, V., Li, Y., Balshem, A., … Schulman, K. A. (2004). An exploration of relative health stock in advanced cancer patients. Medical Decision Making, 24, 614-624. dx.doi.org/10.1177/0272989X04271041
Gaston, C. M., & Mitchell, G. (2005). Information giving and decision-making in patients with advanced cancer: A systematic review. Social Science and Medicine, 61, 2252-2264. dx.doi.org/10.1016/j.socscimed.2005.04.015
Gren, L., Broski, K., Childs, J., Cordes, J., Engelhard, D., Gahagan, B., … Marcus, P. (2009). Recruitment methods employed in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Clinical Trials, 6, 52-59. dx.doi.org/10.1177/1740774508100974
Hlubocky, F. J., Ratain, M. J., Wen, M., & Daugherty, C. K. (2007). Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: A study of prognosis, quality of life, and preferences for decision making. Journal of Clinical Oncology, 25, 548-554. dx.doi.org/10.1200/JCO.2005.03.9800
Horstmann, E., McCabe, M. S., Grochow, L., Yamamoto, S., Rubinstein, L., Budd, T., … Grady, C. (2005). Risks and benefits of phase I oncology trials, 1991 through 2002. New England Journal of Medicine, 352, 895-904. dx.doi.org/10.1056/NEJMsa042220
Humber, C. E., Tierney, J. F., Symonds, R. P., Collingwood, M., Kirwan, J., Williams, C., & Green, J. A. (2007). Chemotherapy for advanced, recurrent or metastatic endometrial cancer: A systematic review of Cochrane collaboration. Annals of Oncology, 18, 409-420. dx.doi.org/10.1093/annonc/mdl417
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009). Cancer statistics, 2009. CA: A Cancer Journal for Clinicians, 59, 225-249. dx.doi.org/10.3322/caac.20006
Joffe, S., & Miller, F. G. (2006). Rethinking risk-benefit assessment for phase I cancer trials. Journal of Clinical Oncology, 24, 2987-2990. dx.doi.org/10.1200/JCO.2005.04.9296
Koyfman, S. A., Agrawal, M., Garrett-Mayer, E., Krohmal, B., Wolf, E., Emanuel, E. J., & Gross, C. P. (2007). Risks and benefits associated with novel phase I oncology trial designs. Cancer, 110, 1115-1124. dx.doi.org/10.1002/cncr.22878
Kumar, A., Soares, H. P., Balducci, L., Djulbegovic, B., & National Cancer Institute. (2007). Treatment tolerance and efficacy in geriatric oncology: A systematic review of phase III randomized trials conducted by five National Cancer Institute sponsored cooperative groups. Journal of Clinical Oncology, 25, 1272-1276. dx.doi.org/10.1200/JCO.2006.09.2759
Kurzrock, R., & Benjamin, R. S. (2005). Risks and benefits of phase I oncology trials, revisited. New England Journal of Medicine, 352, 930-932. dx.doi.org/10.1056/NEJMe058007
Lai, G. Y., Gary, T. L., Tilburt, J., Bolen, S., Baffi, C., Wilson, R. F., … Ford, J. G. (2006). Effectiveness of strategies to recruit underrepresented populations into cancer clinical trials. Clinical Trials, 3, 133-141. dx.doi.org/10.1191/1740774506cn143oa
Lara, P. N., Jr., Paterniti, D. A., Chiechi, C., Turrell, C., Morain, C., Horan, N., … Chen, M. S., Jr. (2005). Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials. Journal of Clinical Oncology, 23, 9282-9289. dx.doi.org/10.1200/JCO.2005.02.6245
Markman, M., Petersen, J., & Montgomery, R. (2006). Influence of tumor type, disease status, and patient age on self-reported interest regarding participation in cancer clinical trials. Cancer, 107, 849-853. dx.doi.org/10.1002/cncr.21997
Mathews, C., Restivo, A., Raker, C., Weitzen, S., & DiSilvestro, P. (2009). Willingness of gynecologic cancer patients to participate in clinical trials. Gynecologic Oncology, 112, 161-165. dx.doi.org/10.1016/j.ygyno.2008.09.003
Meropol, N. J., Buzaglo, J. S., Millard, J., Damjanov, N., Miller, S. M., Ridgway, C., … Watts, P. (2007). Barriers to clinical trial participation as perceived by oncologists and patients. Journal of the National Comprehensive Cancer Network, 5, 655-664.
Meropol, N. J., Weinfurt, K. P., Burnett, C. B., Balshem, A., Benson, A. B., III, Castel, L., … Schulman, K. A. (2003). Perceptions of patients and physicians regarding phase I cancer clinical trials. Implications for physician-patient communication. Journal of Clinical Oncology, 21, 2589-2596. dx.doi.org/10.1200/JCO.2003.10.072
Mills, E. J., Seely, D., Rachlis, B., Griffith, L., Wu, P., Wilson, K., … Wright, J. R. (2006). Barriers to participation in clinical trials of cancer: A meta-analysis and systematic review of patient-reported factors. Lancet Oncology, 7, 141-148. dx.doi.org/10.1016/S1470-2045(06)70576-9
Moazam, F. (2006). Research and developing countries: Hopes and hypes. Eastern Mediterranean Health Journal, 12(Suppl. 1), S30 S36.
Murthy, V. H., Krumholz, H. M., & Gross, C. P. (2004). Participation in cancer clinical trials: Race-, sex-, and age-based disparities. JAMA, 291, 2720-2726. dx.doi.org/10.1001/jama.291.22.2720
National Cancer Institute. (2009). The nation's investment in cancer research: Connecting the nation's cancer community [Publication No.08-6363]. Bethesda, MD: Author.
National Institutes of Health National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. (1979).
The Belmont Report: Ethical principles and guidelines for the protection of human subjects of research. Retrieved from
http://ohsr.od.nih.gov/guidelines/belmont.html
Nguyen, T. T., Somkin, C. P., Ma, Y., Fung, L. C., & Nguyen, T. (2005). Participation of Asian-American women in cancer treatment research: A pilot study. Journal of the National Cancer Institute. Monographs, 35, 102-105. dx.doi.org/10.1093/jncimonographs/lgi046
Quinn, G. P., Bell, B. A., Bell, M. Y., Caraway, V. D., Conforte, D., Graci, L. B., … Bepler, G. (2007). The guinea pig syndrome: Improving clinical trial participation among thoracic patients. Journal of Thoracic Oncology, 2, 191-196. dx.doi.org/10.1097/JTO.0b013e318031cdb6
Seidenfeld, J., Horstmann, E., Emanuel, E. J., & Grady, C. (2008). Participants in phase I oncology research trials: Are they vulnerable? Archives of Internal Medicine, 168, 16-20. dx.doi.org/10.1001/archinternmed.2007.6
Simon, M. S., Du, W., Flaherty, L., Philip, P. A., Lorusso, P., Miree, C., … Brown, D. R. (2004). Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center. Journal of Clinical Oncology, 22, 2046-2052. dx.doi.org/10.1200/JCO.2004.03.005
Stacey, D., Murray, M. A., Legare, F., Sandy, D., Menard, P., & O'Connor, A. (2008). Decision coaching to support shared decision making: A framework, evidence, and implications for nursing practice, education, and policy. Worldviews on Evidence-Based Nursing, 5, 25-35. dx.doi.org/10.1111/j.1741-6787.2007.00108.x
Stacey, D., Samant, R., & Bennett, C. (2008). Decision making in oncology: A review of patient decision aids to support patient participation. CA: A Cancer Journal for Clinicians, 58, 293-304. dx.doi.org/10.3322/CA.2008.0006
Stewart, J. H., Bertoni, A. G., Staten, J. L., Levine, E. A., & Gross, C. P. (2007). Participation in surgical oncology clinical trials: Gender-, race/ethnicity-, and age-based disparities. Annals of Surgical Oncology, 14, 3328-3334. dx.doi.org/10.1245/s10434-007-9500-y
Stryker, J. E., Wray, R. J., Emmons, K. M., Winer, E., & Demetri, G. (2006). Understanding the decisions of cancer clinical trial participants to enter research studies: Factors associated with informed consent, patient satisfaction, and decisional regret. Patient Education and Counseling, 63, 104-109. dx.doi.org/10.1016/j.pec.2005.09.006
Tejeda, H. A., Green, S. B., Trimble, E. L., Ford, L., High, J. L., Ungerleider, R. S., … Brawley, O. W. (1996). Representation of African-Americans, Hispanics, and Caucasians in National Cancer Institute cancer treatment trials.
Journal of the National Cancer Institute, 88, 812-816. Retrieved from
http://jnci.oxfordjournals.org/content/88/12/812.long http://jnci.oxfordjournals.org/content/88/12/812.long
Todd, A. M., Laird, B. J., Boyle, D., Boyd, A. C., Colvin, L. A., & Fallon, M. T. (2009). A systematic review examining the literature on attitudes of patients with advanced cancer toward research. Journal of Pain and Symptom Management, 37, 1078-1085. dx.doi.org/10.1016/j.jpainsymman.2008.07.009
Travis, K. (2009). Psychosocial oncology research faces uncertain future in UK. Journal of the National Cancer Institute, 101, 777-779. dx.doi.org/10.1093/jnci/djp153
Umutyan, A., Chiechi, C., Beckett, L. A., Paterniti, D. A., Turrell, C., Gandara, D. R., … Lara, P. N., Jr. (2008). Overcoming barriers to cancer clinical trial accrual: Impact of a mass media campaign. Cancer, 112, 212-219. dx.doi.org/10.1002/cncr.23170
Unger, J. M., Coltman, C. A., Jr., Crowley, J. J., Hutchins, L. F., Martino, S., Livingston, R. B., … Albain, K. S. (2006). Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials. Journal of Clinical Oncology, 24, 141-144. dx.doi.org/10.1200/JCO.2005.02.8928
Wagner, L. I., Wenzel, L., Shaw, E., & Cella, D. (2007). Patient-reported outcomes in phase II cancer clinical trials: Lessons learned and future directions. Journal of Clinical Oncology, 25, 5058-5062. dx.doi.org/10.1200/JCO.2007.11.7275
Watanabe, Y., Takahashi, M., & Kai, I. (2008). Japanese cancer patient participation in and satisfaction with treatment-related decision-making: A qualitative study. BMC Public Health, 8, 77. dx.doi.org/10.1186/1471-2458-8-77
Weinfurt, K. P., Depuy, V., Castel, L. D., Sulmasy, D. P., Schulman, K. A., & Meropol, N. J. (2005). Understanding of an aggregate probability statement by patients who are offered participation in phase I clinical trials. Cancer, 103, 140-147. dx.doi.org/10.1002/cncr.20730
Wray, R. J., Stryker, J. E. Winer, E., Demetri, G., & Emmons, K. M. (2007). Do cancer patients fully understand clinical trial participation? A pilot study to assess informed consent and patient expectations. Journal of Cancer Education, 22, 21-24. dx.doi.org/10.1080/08858190701348018